IBDEI0A2 ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13489,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13489,1,1,0)
 ;;=1^V10.11
 ;;^UTILITY(U,$J,358.3,13489,1,8,0)
 ;;=8^Hx-Bronchogenic Malignan
 ;;^UTILITY(U,$J,358.3,13489,2)
 ;;=^295211
 ;;^UTILITY(U,$J,358.3,13490,0)
 ;;=V10.12^^83^845^33
 ;;^UTILITY(U,$J,358.3,13490,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13490,1,1,0)
 ;;=1^V10.12
 ;;^UTILITY(U,$J,358.3,13490,1,8,0)
 ;;=8^Hx-Tracheal Malignancy
 ;;^UTILITY(U,$J,358.3,13490,2)
 ;;=^295212
 ;;^UTILITY(U,$J,358.3,13491,0)
 ;;=V10.21^^83^845^21
 ;;^UTILITY(U,$J,358.3,13491,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13491,1,1,0)
 ;;=1^V10.21
 ;;^UTILITY(U,$J,358.3,13491,1,8,0)
 ;;=8^Hx-Laryngeal Malignancy
 ;;^UTILITY(U,$J,358.3,13491,2)
 ;;=^295214
 ;;^UTILITY(U,$J,358.3,13492,0)
 ;;=V10.29^^83^845^20
 ;;^UTILITY(U,$J,358.3,13492,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13492,1,1,0)
 ;;=1^V10.29
 ;;^UTILITY(U,$J,358.3,13492,1,8,0)
 ;;=8^Hx-Intrathoracic Mal Nec
 ;;^UTILITY(U,$J,358.3,13492,2)
 ;;=^295216
 ;;^UTILITY(U,$J,358.3,13493,0)
 ;;=V10.87^^83^845^12
 ;;^UTILITY(U,$J,358.3,13493,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13493,1,1,0)
 ;;=1^V10.87
 ;;^UTILITY(U,$J,358.3,13493,1,8,0)
 ;;=8^Hx Of Thyroid Malignancy
 ;;^UTILITY(U,$J,358.3,13493,2)
 ;;=^295245
 ;;^UTILITY(U,$J,358.3,13494,0)
 ;;=V10.51^^83^845^1
 ;;^UTILITY(U,$J,358.3,13494,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13494,1,1,0)
 ;;=1^V10.51
 ;;^UTILITY(U,$J,358.3,13494,1,8,0)
 ;;=8^Hx Of Bladder Malignancy
 ;;^UTILITY(U,$J,358.3,13494,2)
 ;;=^295228
 ;;^UTILITY(U,$J,358.3,13495,0)
 ;;=V10.52^^83^845^9
 ;;^UTILITY(U,$J,358.3,13495,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13495,1,1,0)
 ;;=1^V10.52
 ;;^UTILITY(U,$J,358.3,13495,1,8,0)
 ;;=8^Hx Of Kidney Malignancy
 ;;^UTILITY(U,$J,358.3,13495,2)
 ;;=^295229
 ;;^UTILITY(U,$J,358.3,13496,0)
 ;;=V10.46^^83^845^29
 ;;^UTILITY(U,$J,358.3,13496,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13496,1,1,0)
 ;;=1^V10.46
 ;;^UTILITY(U,$J,358.3,13496,1,8,0)
 ;;=8^Hx-Prostatic Malignancy
 ;;^UTILITY(U,$J,358.3,13496,2)
 ;;=^295224
 ;;^UTILITY(U,$J,358.3,13497,0)
 ;;=V10.47^^83^845^32
 ;;^UTILITY(U,$J,358.3,13497,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13497,1,1,0)
 ;;=1^V10.47
 ;;^UTILITY(U,$J,358.3,13497,1,8,0)
 ;;=8^Hx-Testicular Malignancy
 ;;^UTILITY(U,$J,358.3,13497,2)
 ;;=^295225
 ;;^UTILITY(U,$J,358.3,13498,0)
 ;;=V10.49^^83^845^23
 ;;^UTILITY(U,$J,358.3,13498,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13498,1,1,0)
 ;;=1^V10.49
 ;;^UTILITY(U,$J,358.3,13498,1,8,0)
 ;;=8^Hx-Male Genit Malig Nec
 ;;^UTILITY(U,$J,358.3,13498,2)
 ;;=^295226
 ;;^UTILITY(U,$J,358.3,13499,0)
 ;;=V10.45^^83^845^24
 ;;^UTILITY(U,$J,358.3,13499,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13499,1,1,0)
 ;;=1^V10.45
 ;;^UTILITY(U,$J,358.3,13499,1,8,0)
 ;;=8^Hx-Male Genit Malig Nos
 ;;^UTILITY(U,$J,358.3,13499,2)
 ;;=^295223
 ;;^UTILITY(U,$J,358.3,13500,0)
 ;;=V10.3^^83^845^4
 ;;^UTILITY(U,$J,358.3,13500,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13500,1,1,0)
 ;;=1^V10.3
 ;;^UTILITY(U,$J,358.3,13500,1,8,0)
 ;;=8^Hx Of Breast Malignancy
 ;;^UTILITY(U,$J,358.3,13500,2)
 ;;=^295217
 ;;^UTILITY(U,$J,358.3,13501,0)
 ;;=V10.41^^83^845^15
 ;;^UTILITY(U,$J,358.3,13501,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13501,1,1,0)
 ;;=1^V10.41
 ;;^UTILITY(U,$J,358.3,13501,1,8,0)
 ;;=8^Hx-Cervical Malignancy
 ;;^UTILITY(U,$J,358.3,13501,2)
 ;;=^295219
 ;;^UTILITY(U,$J,358.3,13502,0)
 ;;=V10.42^^83^845^34
 ;;^UTILITY(U,$J,358.3,13502,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13502,1,1,0)
 ;;=1^V10.42
 ;;^UTILITY(U,$J,358.3,13502,1,8,0)
 ;;=8^Hx-Uterus Malignancy Nec
 ;;^UTILITY(U,$J,358.3,13502,2)
 ;;=^295220
 ;;^UTILITY(U,$J,358.3,13503,0)
 ;;=V10.43^^83^845^11
 ;;^UTILITY(U,$J,358.3,13503,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13503,1,1,0)
 ;;=1^V10.43
 ;;^UTILITY(U,$J,358.3,13503,1,8,0)
 ;;=8^Hx Of Ovarian Malignancy
 ;;^UTILITY(U,$J,358.3,13503,2)
 ;;=^295221
 ;;^UTILITY(U,$J,358.3,13504,0)
 ;;=V10.44^^83^845^18
 ;;^UTILITY(U,$J,358.3,13504,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13504,1,1,0)
 ;;=1^V10.44
 ;;^UTILITY(U,$J,358.3,13504,1,8,0)
 ;;=8^Hx-Female Genit Malg Nec
 ;;^UTILITY(U,$J,358.3,13504,2)
 ;;=^295222
 ;;^UTILITY(U,$J,358.3,13505,0)
 ;;=V10.81^^83^845^2
 ;;^UTILITY(U,$J,358.3,13505,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13505,1,1,0)
 ;;=1^V10.81
 ;;^UTILITY(U,$J,358.3,13505,1,8,0)
 ;;=8^Hx Of Bone Malignancy
 ;;^UTILITY(U,$J,358.3,13505,2)
 ;;=^295239
 ;;^UTILITY(U,$J,358.3,13506,0)
 ;;=V10.82^^83^845^25
 ;;^UTILITY(U,$J,358.3,13506,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13506,1,1,0)
 ;;=1^V10.82
 ;;^UTILITY(U,$J,358.3,13506,1,8,0)
 ;;=8^Hx-Malig Skin Melanoma
 ;;^UTILITY(U,$J,358.3,13506,2)
 ;;=^295240
 ;;^UTILITY(U,$J,358.3,13507,0)
 ;;=V10.83^^83^845^31
 ;;^UTILITY(U,$J,358.3,13507,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13507,1,1,0)
 ;;=1^V10.83
 ;;^UTILITY(U,$J,358.3,13507,1,8,0)
 ;;=8^Hx-Skin Malignancy Nec
 ;;^UTILITY(U,$J,358.3,13507,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,13508,0)
 ;;=V10.84^^83^845^6
 ;;^UTILITY(U,$J,358.3,13508,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13508,1,1,0)
 ;;=1^V10.84
 ;;^UTILITY(U,$J,358.3,13508,1,8,0)
 ;;=8^Hx Of Eye Malignancy
 ;;^UTILITY(U,$J,358.3,13508,2)
 ;;=^295242
 ;;^UTILITY(U,$J,358.3,13509,0)
 ;;=V10.85^^83^845^3
 ;;^UTILITY(U,$J,358.3,13509,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13509,1,1,0)
 ;;=1^V10.85
 ;;^UTILITY(U,$J,358.3,13509,1,8,0)
 ;;=8^Hx Of Brain Malignancy
 ;;^UTILITY(U,$J,358.3,13509,2)
 ;;=^295243
 ;;^UTILITY(U,$J,358.3,13510,0)
 ;;=V10.86^^83^845^26
 ;;^UTILITY(U,$J,358.3,13510,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13510,1,1,0)
 ;;=1^V10.86
 ;;^UTILITY(U,$J,358.3,13510,1,8,0)
 ;;=8^Hx-Malign Nerve Syst Nec
 ;;^UTILITY(U,$J,358.3,13510,2)
 ;;=^295244
 ;;^UTILITY(U,$J,358.3,13511,0)
 ;;=V10.88^^83^845^16
 ;;^UTILITY(U,$J,358.3,13511,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13511,1,1,0)
 ;;=1^V10.88
 ;;^UTILITY(U,$J,358.3,13511,1,8,0)
 ;;=8^Hx-Endocrine Malign Nec
 ;;^UTILITY(U,$J,358.3,13511,2)
 ;;=^295246
 ;;^UTILITY(U,$J,358.3,13512,0)
 ;;=238.0^^83^846^1
 ;;^UTILITY(U,$J,358.3,13512,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13512,1,1,0)
 ;;=1^238.0
 ;;^UTILITY(U,$J,358.3,13512,1,8,0)
 ;;=8^Bone and Articular Cartilage
 ;;^UTILITY(U,$J,358.3,13512,2)
 ;;=^81953
 ;;^UTILITY(U,$J,358.3,13513,0)
 ;;=238.1^^83^846^3
 ;;^UTILITY(U,$J,358.3,13513,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13513,1,1,0)
 ;;=1^238.1
 ;;^UTILITY(U,$J,358.3,13513,1,8,0)
 ;;=8^Connective and Oth Soft Tissue
 ;;^UTILITY(U,$J,358.3,13513,2)
 ;;=^267776
 ;;^UTILITY(U,$J,358.3,13514,0)
 ;;=238.2^^83^846^17
 ;;^UTILITY(U,$J,358.3,13514,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13514,1,1,0)
 ;;=1^238.2
 ;;^UTILITY(U,$J,358.3,13514,1,8,0)
 ;;=8^Skin
 ;;^UTILITY(U,$J,358.3,13514,2)
 ;;=^267777
 ;;^UTILITY(U,$J,358.3,13515,0)
 ;;=238.3^^83^846^2
 ;;^UTILITY(U,$J,358.3,13515,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13515,1,1,0)
 ;;=1^238.3
 ;;^UTILITY(U,$J,358.3,13515,1,8,0)
 ;;=8^Breast
 ;;^UTILITY(U,$J,358.3,13515,2)
 ;;=^81956
 ;;^UTILITY(U,$J,358.3,13516,0)
 ;;=238.4^^83^846^15
 ;;^UTILITY(U,$J,358.3,13516,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13516,1,1,0)
 ;;=1^238.4
 ;;^UTILITY(U,$J,358.3,13516,1,8,0)
 ;;=8^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,13516,2)
 ;;=^304816
 ;;^UTILITY(U,$J,358.3,13517,0)
 ;;=238.5^^83^846^6
 ;;^UTILITY(U,$J,358.3,13517,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13517,1,1,0)
 ;;=1^238.5
 ;;^UTILITY(U,$J,358.3,13517,1,8,0)
 ;;=8^Histiocytic and Mast Cells
 ;;^UTILITY(U,$J,358.3,13517,2)
 ;;=^267778
 ;;^UTILITY(U,$J,358.3,13518,0)
 ;;=238.6^^83^846^14
 ;;^UTILITY(U,$J,358.3,13518,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13518,1,1,0)
 ;;=1^238.6
 ;;^UTILITY(U,$J,358.3,13518,1,8,0)
 ;;=8^Plasma Cells
 ;;^UTILITY(U,$J,358.3,13518,2)
 ;;=^81973
 ;;^UTILITY(U,$J,358.3,13519,0)
 ;;=238.71^^83^846^4
 ;;^UTILITY(U,$J,358.3,13519,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13519,1,1,0)
 ;;=1^238.71
 ;;^UTILITY(U,$J,358.3,13519,1,8,0)
 ;;=8^Essential Thrombocythemia
 ;;^UTILITY(U,$J,358.3,13519,2)
 ;;=^334027
 ;;^UTILITY(U,$J,358.3,13520,0)
 ;;=238.72^^83^846^7
 ;;^UTILITY(U,$J,358.3,13520,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13520,1,1,0)
 ;;=1^238.72
 ;;^UTILITY(U,$J,358.3,13520,1,8,0)
 ;;=8^Low Grade Myelody Synd Lesion
 ;;^UTILITY(U,$J,358.3,13520,2)
 ;;=^334028
 ;;^UTILITY(U,$J,358.3,13521,0)
 ;;=238.73^^83^846^5
 ;;^UTILITY(U,$J,358.3,13521,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13521,1,1,0)
 ;;=1^238.73
 ;;^UTILITY(U,$J,358.3,13521,1,8,0)
 ;;=8^High Grade Myelody Synd Lesion
 ;;^UTILITY(U,$J,358.3,13521,2)
 ;;=^334029
 ;;^UTILITY(U,$J,358.3,13522,0)
 ;;=238.74^^83^846^9
 ;;^UTILITY(U,$J,358.3,13522,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13522,1,1,0)
 ;;=1^238.74
 ;;^UTILITY(U,$J,358.3,13522,1,8,0)
 ;;=8^Myelody Synd w/ 5q Deletion
 ;;^UTILITY(U,$J,358.3,13522,2)
 ;;=^334030
 ;;^UTILITY(U,$J,358.3,13523,0)
 ;;=238.75^^83^846^10
 ;;^UTILITY(U,$J,358.3,13523,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13523,1,1,0)
 ;;=1^238.75
 ;;^UTILITY(U,$J,358.3,13523,1,8,0)
 ;;=8^Myelodysplastic Syndrome
 ;;^UTILITY(U,$J,358.3,13523,2)
 ;;=^334031
 ;;^UTILITY(U,$J,358.3,13524,0)
 ;;=238.76^^83^846^11
 ;;^UTILITY(U,$J,358.3,13524,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13524,1,1,0)
 ;;=1^238.76
 ;;^UTILITY(U,$J,358.3,13524,1,8,0)
 ;;=8^Myelofibrosis w/Myeloid Metaplasia
 ;;^UTILITY(U,$J,358.3,13524,2)
 ;;=^334032
 ;;^UTILITY(U,$J,358.3,13525,0)
 ;;=238.77^^83^846^16
 ;;^UTILITY(U,$J,358.3,13525,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,13525,1,1,0)
 ;;=1^238.77
 ;;^UTILITY(U,$J,358.3,13525,1,8,0)
 ;;=8^Post Transp Lymphoprolif d/o PTLD
 ;;^UTILITY(U,$J,358.3,13525,2)
 ;;=^336526
 ;;^UTILITY(U,$J,358.3,13526,0)
 ;;=238.79^^83^846^12
 ;;^UTILITY(U,$J,358.3,13526,1,0)
 ;;=^358.31IA^8^2
